HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bassam Francis Matti Selected Research

FLAG protocol

12/2014The Efficacy of Fludarabine, High Dose Cytosine Arabinoside with Granulocyte Colony Stimulating Factor (FLAG) Protocol as Salvage Therapy for Refractory/Relapsed Acute Leukemias in Adult Iraqi Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bassam Francis Matti Research Topics

Disease

2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
12/2014 - 12/2013
1Leukemia
12/2014
1Neoplasms (Cancer)
12/2014

Drug/Important Bio-Agent (IBA)

1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2014
1CytokinesIBA
12/2014
1fludarabineIBA
12/2014
1Cytarabine (Cytosar-U)FDA LinkGeneric
12/2014
1InterleukinsIBA
12/2014
1Mesylates (Mesylate)IBA
12/2014
1Tyrosine Kinase InhibitorsIBA
12/2013
1Imatinib Mesylate (Gleevec)FDA Link
12/2013
1Pharmaceutical PreparationsIBA
12/2013

Therapy/Procedure

1FLAG protocol
12/2014
1Salvage Therapy
12/2014
1Therapeutics
12/2014